CN Stock MarketDetailed Quotes

688506 Sichuan Biokin Pharmaceutical

Watchlist
  • 195.72
  • +32.62+20.00%
Market Closed Sep 30 15:00 CST
78.48BMarket Cap18.62P/E (TTM)

Sichuan Biokin Pharmaceutical Key Stats

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
Total operating revenue
1,685.19%5.55B
4,325.45%5.46B
-20.11%561.87M
-21.37%377.7M
2.06%311.04M
1.74%123.43M
-11.73%703.28M
-21.75%480.34M
-27.97%304.76M
121.31M
Operating revenue
1,685.19%5.55B
4,325.45%5.46B
-20.11%561.87M
-21.37%377.7M
2.06%311.04M
1.74%123.43M
-11.73%703.28M
-21.75%480.34M
-27.97%304.76M
--121.31M
Total operating cost
15.71%759.99M
29.87%386.89M
31.36%1.37B
26.45%943.85M
43.32%656.84M
65.18%297.91M
8.26%1.05B
7.13%746.41M
458.3M
180.35M
Operating cost
-0.81%111.4M
25.75%58.92M
-1.48%229.28M
-4.02%145.2M
29.79%112.3M
56.72%46.85M
17.71%232.74M
6.43%151.29M
-4.31%86.53M
--29.9M
Operating tax surcharges
28.78%6.2M
127.81%3.25M
-23.34%10.48M
-40.62%5.42M
-12.38%4.81M
-36.67%1.43M
-3.29%13.67M
-16.98%9.12M
--5.49M
--2.25M
Operating expense
-24.07%106.99M
0.54%58.03M
-22.54%251.19M
-20.83%179.72M
-3.14%140.89M
4.98%57.72M
-17.12%324.3M
-25.58%227.01M
--145.46M
--54.98M
Administration expense
28.63%71.29M
1.14%27.18M
48.26%116.7M
47.97%88.41M
46.16%55.42M
48.70%26.87M
3.35%78.71M
8.07%59.75M
--37.92M
--18.07M
Financial expense
-860.43%-80.41M
-251.96%-9.26M
-5.70%20.76M
-2.20%15.3M
9.24%10.57M
40.32%6.09M
154.18%22.02M
168.15%15.65M
--9.68M
--4.34M
-Interest expense (Financial expense)
32.82%16.65M
12.14%7.14M
9.78%24.68M
15.42%18.49M
25.85%12.53M
42.72%6.37M
158.64%22.48M
179.95%16.02M
--9.96M
--4.46M
-Interest Income (Financial expense)
-2,905.23%-84.94M
-3,673.16%-21.01M
-643.96%-5.7M
-660.04%-4.37M
-631.01%-2.83M
-161.13%-556.88K
-61.45%-766.6K
-140.94%-575.4K
---386.63K
---213.26K
Research and development
63.61%544.53M
56.52%248.77M
98.98%746.23M
79.77%509.8M
92.14%332.83M
124.47%158.94M
34.61%375.02M
59.82%283.59M
53.69%173.23M
--70.8M
Credit Impairment Loss
-43.49%968.47K
-115.45%-263.11K
183.82%6.44M
313.08%6.22M
221.57%1.71M
408.63%1.7M
-356.32%-7.69M
-208.23%-2.92M
---1.41M
--334.83K
Asset Impairment Loss
-50.69%-9.22M
-23.87%-5.86M
-161.45%-12.98M
-145.14%-9.63M
-146.81%-6.12M
-374.12%-4.73M
12.44%-4.96M
-13.62%-3.93M
---2.48M
---997.35K
Other net revenue
Fair value change income
--13.56M
----
----
----
----
----
----
----
----
----
Invest income
----
----
--3.9K
--3.9K
--3.9K
--3.9K
----
----
----
----
Asset deal income
----
----
853.26%146.39K
853.26%146.39K
853.26%146.39K
853.26%146.39K
-308.89%-19.43K
-308.89%-19.43K
---19.43K
---19.43K
Other revenue
345.67%30.28M
233.64%4.21M
-27.01%49.79M
49.71%35.15M
-66.07%6.79M
-93.14%1.26M
0.44%68.21M
-59.35%23.48M
--20.02M
--18.4M
Operating profit
1,506.63%4.83B
2,981.04%5.07B
-167.48%-769.38M
-114.17%-534.25M
-149.76%-343.25M
-326.22%-176.09M
-183.49%-287.63M
-996.27%-249.46M
-418.56%-137.43M
-41.32M
Add:Non operating Income
-97.65%53.38K
-98.32%17.93K
3,461.65%2.3M
4,523.39%2.29M
4,820.73%2.27M
2,852.26%1.07M
-57.25%64.62K
-57.98%49.48K
--46.11K
--36.1K
Less:Non operating expense
2.88%639.25K
-63.18%145.65K
28.89%1.94M
25.07%1.73M
-53.09%621.36K
-63.66%395.53K
-51.90%1.5M
-50.70%1.38M
--1.32M
--1.09M
Total profit
1,513.24%4.83B
2,991.97%5.07B
-166.03%-769.01M
-112.81%-533.7M
-146.27%-341.61M
-314.05%-175.42M
-176.79%-289.07M
-885.76%-250.79M
-379.09%-138.71M
-42.37M
Less:Income tax cost
1,314.64%161.39M
891.75%68.04M
271.57%11.49M
-132.85%-18.59M
-1,210.80%-13.29M
-367.30%-8.59M
-50.60%-6.69M
-229.45%-7.98M
---1.01M
--3.21M
Net profit
FLtoP4.67B
FLtoP5.01B
FPtoL-780.5M
FPtoL-515.11M
FPtoL-328.32M
FPtoL-166.83M
FPtoL-282.38M
FPtoL-242.81M
FPtoL-137.7M
-45.58M
Net profit from continuing operation
1,521.28%4.67B
3,100.16%5.01B
-176.40%-780.5M
-112.15%-515.11M
-138.43%-328.32M
-265.99%-166.83M
-182.40%-282.38M
-954.86%-242.81M
---137.7M
---45.58M
Net profit of parent company owners
1,521.28%4.67B
3,100.16%5.01B
-176.40%-780.5M
-112.15%-515.11M
-138.43%-328.32M
-265.99%-166.83M
-182.40%-282.38M
-954.86%-242.81M
-486.36%-137.7M
---45.58M
Earning per share
Basic earning per share
1,519.51%11.64
3,071.43%12.48
-150.00%-1.95
-91.04%-1.28
-115.79%-0.82
-223.08%-0.42
-178.57%-0.78
-1,016.67%-0.67
---0.38
---0.13
Diluted earning per share
1,519.51%11.64
3,071.43%12.48
-150.00%-1.95
-91.04%-1.28
-115.79%-0.82
-223.08%-0.42
-178.57%-0.78
-1,016.67%-0.67
---0.38
---0.13
Other composite income
395.52%7.86M
56.28%-1.45M
-4,972.93%-1.67M
-183.46%-2.41M
-463.35%-2.66M
-4,383.76%-3.31M
110.16%34.22K
2,305.20%2.89M
731.66K
77.25K
Other composite income of parent company owners
----
56.28%-1.45M
-4,972.93%-1.67M
-183.46%-2.41M
----
-4,383.76%-3.31M
110.16%34.22K
2,305.20%2.89M
--731.66K
--77.25K
Total composite income
1,512.24%4.67B
3,040.95%5B
-177.03%-782.17M
-115.70%-517.51M
-141.65%-330.98M
-273.89%-170.14M
-181.42%-282.34M
-947.78%-239.92M
-136.97M
-45.51M
Total composite income of parent company owners
1,512.24%4.67B
3,040.95%5B
-177.03%-782.17M
-115.70%-517.51M
-141.65%-330.98M
-273.89%-170.14M
-181.42%-282.34M
-947.78%-239.92M
---136.97M
---45.51M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
Unqualified opinion
--
--
--
--
--
--
--
Auditor
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022
Total operating revenue 1,685.19%5.55B4,325.45%5.46B-20.11%561.87M-21.37%377.7M2.06%311.04M1.74%123.43M-11.73%703.28M-21.75%480.34M-27.97%304.76M121.31M
Operating revenue 1,685.19%5.55B4,325.45%5.46B-20.11%561.87M-21.37%377.7M2.06%311.04M1.74%123.43M-11.73%703.28M-21.75%480.34M-27.97%304.76M--121.31M
Total operating cost 15.71%759.99M29.87%386.89M31.36%1.37B26.45%943.85M43.32%656.84M65.18%297.91M8.26%1.05B7.13%746.41M458.3M180.35M
Operating cost -0.81%111.4M25.75%58.92M-1.48%229.28M-4.02%145.2M29.79%112.3M56.72%46.85M17.71%232.74M6.43%151.29M-4.31%86.53M--29.9M
Operating tax surcharges 28.78%6.2M127.81%3.25M-23.34%10.48M-40.62%5.42M-12.38%4.81M-36.67%1.43M-3.29%13.67M-16.98%9.12M--5.49M--2.25M
Operating expense -24.07%106.99M0.54%58.03M-22.54%251.19M-20.83%179.72M-3.14%140.89M4.98%57.72M-17.12%324.3M-25.58%227.01M--145.46M--54.98M
Administration expense 28.63%71.29M1.14%27.18M48.26%116.7M47.97%88.41M46.16%55.42M48.70%26.87M3.35%78.71M8.07%59.75M--37.92M--18.07M
Financial expense -860.43%-80.41M-251.96%-9.26M-5.70%20.76M-2.20%15.3M9.24%10.57M40.32%6.09M154.18%22.02M168.15%15.65M--9.68M--4.34M
-Interest expense (Financial expense) 32.82%16.65M12.14%7.14M9.78%24.68M15.42%18.49M25.85%12.53M42.72%6.37M158.64%22.48M179.95%16.02M--9.96M--4.46M
-Interest Income (Financial expense) -2,905.23%-84.94M-3,673.16%-21.01M-643.96%-5.7M-660.04%-4.37M-631.01%-2.83M-161.13%-556.88K-61.45%-766.6K-140.94%-575.4K---386.63K---213.26K
Research and development 63.61%544.53M56.52%248.77M98.98%746.23M79.77%509.8M92.14%332.83M124.47%158.94M34.61%375.02M59.82%283.59M53.69%173.23M--70.8M
Credit Impairment Loss -43.49%968.47K-115.45%-263.11K183.82%6.44M313.08%6.22M221.57%1.71M408.63%1.7M-356.32%-7.69M-208.23%-2.92M---1.41M--334.83K
Asset Impairment Loss -50.69%-9.22M-23.87%-5.86M-161.45%-12.98M-145.14%-9.63M-146.81%-6.12M-374.12%-4.73M12.44%-4.96M-13.62%-3.93M---2.48M---997.35K
Other net revenue
Fair value change income --13.56M------------------------------------
Invest income ----------3.9K--3.9K--3.9K--3.9K----------------
Asset deal income --------853.26%146.39K853.26%146.39K853.26%146.39K853.26%146.39K-308.89%-19.43K-308.89%-19.43K---19.43K---19.43K
Other revenue 345.67%30.28M233.64%4.21M-27.01%49.79M49.71%35.15M-66.07%6.79M-93.14%1.26M0.44%68.21M-59.35%23.48M--20.02M--18.4M
Operating profit 1,506.63%4.83B2,981.04%5.07B-167.48%-769.38M-114.17%-534.25M-149.76%-343.25M-326.22%-176.09M-183.49%-287.63M-996.27%-249.46M-418.56%-137.43M-41.32M
Add:Non operating Income -97.65%53.38K-98.32%17.93K3,461.65%2.3M4,523.39%2.29M4,820.73%2.27M2,852.26%1.07M-57.25%64.62K-57.98%49.48K--46.11K--36.1K
Less:Non operating expense 2.88%639.25K-63.18%145.65K28.89%1.94M25.07%1.73M-53.09%621.36K-63.66%395.53K-51.90%1.5M-50.70%1.38M--1.32M--1.09M
Total profit 1,513.24%4.83B2,991.97%5.07B-166.03%-769.01M-112.81%-533.7M-146.27%-341.61M-314.05%-175.42M-176.79%-289.07M-885.76%-250.79M-379.09%-138.71M-42.37M
Less:Income tax cost 1,314.64%161.39M891.75%68.04M271.57%11.49M-132.85%-18.59M-1,210.80%-13.29M-367.30%-8.59M-50.60%-6.69M-229.45%-7.98M---1.01M--3.21M
Net profit FLtoP4.67BFLtoP5.01BFPtoL-780.5MFPtoL-515.11MFPtoL-328.32MFPtoL-166.83MFPtoL-282.38MFPtoL-242.81MFPtoL-137.7M-45.58M
Net profit from continuing operation 1,521.28%4.67B3,100.16%5.01B-176.40%-780.5M-112.15%-515.11M-138.43%-328.32M-265.99%-166.83M-182.40%-282.38M-954.86%-242.81M---137.7M---45.58M
Net profit of parent company owners 1,521.28%4.67B3,100.16%5.01B-176.40%-780.5M-112.15%-515.11M-138.43%-328.32M-265.99%-166.83M-182.40%-282.38M-954.86%-242.81M-486.36%-137.7M---45.58M
Earning per share
Basic earning per share 1,519.51%11.643,071.43%12.48-150.00%-1.95-91.04%-1.28-115.79%-0.82-223.08%-0.42-178.57%-0.78-1,016.67%-0.67---0.38---0.13
Diluted earning per share 1,519.51%11.643,071.43%12.48-150.00%-1.95-91.04%-1.28-115.79%-0.82-223.08%-0.42-178.57%-0.78-1,016.67%-0.67---0.38---0.13
Other composite income 395.52%7.86M56.28%-1.45M-4,972.93%-1.67M-183.46%-2.41M-463.35%-2.66M-4,383.76%-3.31M110.16%34.22K2,305.20%2.89M731.66K77.25K
Other composite income of parent company owners ----56.28%-1.45M-4,972.93%-1.67M-183.46%-2.41M-----4,383.76%-3.31M110.16%34.22K2,305.20%2.89M--731.66K--77.25K
Total composite income 1,512.24%4.67B3,040.95%5B-177.03%-782.17M-115.70%-517.51M-141.65%-330.98M-273.89%-170.14M-181.42%-282.34M-947.78%-239.92M-136.97M-45.51M
Total composite income of parent company owners 1,512.24%4.67B3,040.95%5B-177.03%-782.17M-115.70%-517.51M-141.65%-330.98M-273.89%-170.14M-181.42%-282.34M-947.78%-239.92M---136.97M---45.51M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ----Unqualified opinion--------------
Auditor ----Lixin Certified Public Accountants (Special General Partnership)------Lixin Certified Public Accountants (Special General Partnership)------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data